nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CES1—Capecitabine—colon cancer	0.531	0.593	CbGbCtD
Ciclesonide—CES1—Irinotecan—colon cancer	0.328	0.367	CbGbCtD
Ciclesonide—CYP3A4—Irinotecan—colon cancer	0.0193	0.0216	CbGbCtD
Ciclesonide—CYP3A4—Vincristine—colon cancer	0.0169	0.0189	CbGbCtD
Ciclesonide—Nasal ulcer—Capecitabine—colon cancer	0.00856	0.0925	CcSEcCtD
Ciclesonide—Nasal discomfort—Fluorouracil—colon cancer	0.00404	0.0437	CcSEcCtD
Ciclesonide—Tonsillitis—Capecitabine—colon cancer	0.00319	0.0345	CcSEcCtD
Ciclesonide—Obstructive airways disorder—Methotrexate—colon cancer	0.00265	0.0286	CcSEcCtD
Ciclesonide—CES1—gall bladder—colon cancer	0.0021	0.166	CbGeAlD
Ciclesonide—Hoarseness—Capecitabine—colon cancer	0.00183	0.0198	CcSEcCtD
Ciclesonide—Impaired healing—Methotrexate—colon cancer	0.00139	0.015	CcSEcCtD
Ciclesonide—Ulcer—Irinotecan—colon cancer	0.00127	0.0138	CcSEcCtD
Ciclesonide—Oral candidiasis—Capecitabine—colon cancer	0.00127	0.0137	CcSEcCtD
Ciclesonide—Ulcer—Fluorouracil—colon cancer	0.00122	0.0132	CcSEcCtD
Ciclesonide—Pharyngolaryngeal pain—Capecitabine—colon cancer	0.0012	0.0129	CcSEcCtD
Ciclesonide—Laryngeal pain—Capecitabine—colon cancer	0.00118	0.0128	CcSEcCtD
Ciclesonide—Osteoporosis—Methotrexate—colon cancer	0.00107	0.0116	CcSEcCtD
Ciclesonide—Fracture—Methotrexate—colon cancer	0.00103	0.0112	CcSEcCtD
Ciclesonide—Multiple fractures—Methotrexate—colon cancer	0.00103	0.0112	CcSEcCtD
Ciclesonide—SERPINA6—renal system—colon cancer	0.001	0.0795	CbGeAlD
Ciclesonide—Rhinorrhoea—Capecitabine—colon cancer	0.000996	0.0108	CcSEcCtD
Ciclesonide—Dysphonia—Capecitabine—colon cancer	0.000981	0.0106	CcSEcCtD
Ciclesonide—Swelling—Fluorouracil—colon cancer	0.00095	0.0103	CcSEcCtD
Ciclesonide—Contusion—Capecitabine—colon cancer	0.000925	0.00999	CcSEcCtD
Ciclesonide—Chest discomfort—Capecitabine—colon cancer	0.000912	0.00985	CcSEcCtD
Ciclesonide—Pain in extremity—Vincristine—colon cancer	0.000899	0.00971	CcSEcCtD
Ciclesonide—Oropharyngeal pain—Capecitabine—colon cancer	0.000887	0.00959	CcSEcCtD
Ciclesonide—Ulcer—Capecitabine—colon cancer	0.000853	0.00922	CcSEcCtD
Ciclesonide—Cataract—Capecitabine—colon cancer	0.000848	0.00916	CcSEcCtD
Ciclesonide—CES1—lymphoid tissue—colon cancer	0.000835	0.0661	CbGeAlD
Ciclesonide—CES1—digestive system—colon cancer	0.000825	0.0653	CbGeAlD
Ciclesonide—Candida infection—Capecitabine—colon cancer	0.00077	0.00832	CcSEcCtD
Ciclesonide—SERPINA6—bone marrow—colon cancer	0.00076	0.0601	CbGeAlD
Ciclesonide—Nasopharyngitis—Fluorouracil—colon cancer	0.00075	0.0081	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Irinotecan—colon cancer	0.000703	0.0076	CcSEcCtD
Ciclesonide—Pneumonia—Vincristine—colon cancer	0.000697	0.00753	CcSEcCtD
Ciclesonide—Ear pain—Capecitabine—colon cancer	0.000687	0.00742	CcSEcCtD
Ciclesonide—Pneumonia—Irinotecan—colon cancer	0.000678	0.00733	CcSEcCtD
Ciclesonide—Diabetes mellitus—Capecitabine—colon cancer	0.000673	0.00728	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000673	0.00727	CcSEcCtD
Ciclesonide—Swelling—Capecitabine—colon cancer	0.000664	0.00717	CcSEcCtD
Ciclesonide—Gastroenteritis—Capecitabine—colon cancer	0.000661	0.00714	CcSEcCtD
Ciclesonide—Pneumonia—Fluorouracil—colon cancer	0.00065	0.00702	CcSEcCtD
Ciclesonide—Infestation NOS—Fluorouracil—colon cancer	0.000646	0.00698	CcSEcCtD
Ciclesonide—Infestation—Fluorouracil—colon cancer	0.000646	0.00698	CcSEcCtD
Ciclesonide—Ulcer—Methotrexate—colon cancer	0.000635	0.00686	CcSEcCtD
Ciclesonide—Conjunctivitis—Fluorouracil—colon cancer	0.000628	0.00678	CcSEcCtD
Ciclesonide—Urinary tract infection—Fluorouracil—colon cancer	0.000628	0.00678	CcSEcCtD
Ciclesonide—CES1—liver—colon cancer	0.000615	0.0486	CbGeAlD
Ciclesonide—SERPINA6—liver—colon cancer	0.000614	0.0486	CbGeAlD
Ciclesonide—Epistaxis—Fluorouracil—colon cancer	0.000609	0.00658	CcSEcCtD
Ciclesonide—Haemoglobin—Irinotecan—colon cancer	0.000609	0.00657	CcSEcCtD
Ciclesonide—Rhinitis—Irinotecan—colon cancer	0.000607	0.00656	CcSEcCtD
Ciclesonide—Sinusitis—Fluorouracil—colon cancer	0.000606	0.00655	CcSEcCtD
Ciclesonide—Haemorrhage—Irinotecan—colon cancer	0.000605	0.00654	CcSEcCtD
Ciclesonide—Pain in extremity—Capecitabine—colon cancer	0.000586	0.00633	CcSEcCtD
Ciclesonide—Haemoglobin—Fluorouracil—colon cancer	0.000583	0.0063	CcSEcCtD
Ciclesonide—NR3C1—embryo—colon cancer	0.000581	0.046	CbGeAlD
Ciclesonide—Rhinitis—Fluorouracil—colon cancer	0.000581	0.00628	CcSEcCtD
Ciclesonide—Haemorrhage—Fluorouracil—colon cancer	0.00058	0.00627	CcSEcCtD
Ciclesonide—Pharyngitis—Fluorouracil—colon cancer	0.000576	0.00622	CcSEcCtD
Ciclesonide—Face oedema—Capecitabine—colon cancer	0.000565	0.00611	CcSEcCtD
Ciclesonide—Mediastinal disorder—Vincristine—colon cancer	0.00056	0.00605	CcSEcCtD
Ciclesonide—Immune system disorder—Irinotecan—colon cancer	0.000547	0.00591	CcSEcCtD
Ciclesonide—Mediastinal disorder—Irinotecan—colon cancer	0.000546	0.0059	CcSEcCtD
Ciclesonide—Nasopharyngitis—Capecitabine—colon cancer	0.000524	0.00566	CcSEcCtD
Ciclesonide—Back pain—Vincristine—colon cancer	0.000523	0.00566	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000517	0.00558	CcSEcCtD
Ciclesonide—Back pain—Irinotecan—colon cancer	0.00051	0.00551	CcSEcCtD
Ciclesonide—Influenza—Capecitabine—colon cancer	0.000506	0.00547	CcSEcCtD
Ciclesonide—Diabetes mellitus—Methotrexate—colon cancer	0.000501	0.00542	CcSEcCtD
Ciclesonide—Bronchospasm—Capecitabine—colon cancer	0.000498	0.00538	CcSEcCtD
Ciclesonide—Bronchitis—Capecitabine—colon cancer	0.000487	0.00526	CcSEcCtD
Ciclesonide—NR3C1—epithelium—colon cancer	0.000474	0.0376	CbGeAlD
Ciclesonide—CES1—lymph node—colon cancer	0.000471	0.0373	CbGeAlD
Ciclesonide—Upper respiratory tract infection—Capecitabine—colon cancer	0.000471	0.00508	CcSEcCtD
Ciclesonide—Hypertension—Vincristine—colon cancer	0.000467	0.00505	CcSEcCtD
Ciclesonide—Weight increased—Capecitabine—colon cancer	0.000461	0.00498	CcSEcCtD
Ciclesonide—Cough—Irinotecan—colon cancer	0.00046	0.00497	CcSEcCtD
Ciclesonide—NR3C1—smooth muscle tissue—colon cancer	0.000457	0.0362	CbGeAlD
Ciclesonide—Hypertension—Irinotecan—colon cancer	0.000455	0.00492	CcSEcCtD
Ciclesonide—Pneumonia—Capecitabine—colon cancer	0.000454	0.00491	CcSEcCtD
Ciclesonide—Infestation NOS—Capecitabine—colon cancer	0.000451	0.00488	CcSEcCtD
Ciclesonide—Infestation—Capecitabine—colon cancer	0.000451	0.00488	CcSEcCtD
Ciclesonide—NR3C1—renal system—colon cancer	0.00044	0.0348	CbGeAlD
Ciclesonide—Infection—Vincristine—colon cancer	0.000439	0.00474	CcSEcCtD
Ciclesonide—Conjunctivitis—Capecitabine—colon cancer	0.000439	0.00474	CcSEcCtD
Ciclesonide—Urinary tract infection—Capecitabine—colon cancer	0.000439	0.00474	CcSEcCtD
Ciclesonide—Chest pain—Fluorouracil—colon cancer	0.00043	0.00464	CcSEcCtD
Ciclesonide—Infection—Irinotecan—colon cancer	0.000427	0.00462	CcSEcCtD
Ciclesonide—Epistaxis—Capecitabine—colon cancer	0.000426	0.0046	CcSEcCtD
Ciclesonide—Infection—Fluorouracil—colon cancer	0.000409	0.00442	CcSEcCtD
Ciclesonide—Haemoglobin—Capecitabine—colon cancer	0.000407	0.0044	CcSEcCtD
Ciclesonide—Rhinitis—Capecitabine—colon cancer	0.000406	0.00439	CcSEcCtD
Ciclesonide—Haemorrhage—Capecitabine—colon cancer	0.000405	0.00438	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Vincristine—colon cancer	0.000402	0.00435	CcSEcCtD
Ciclesonide—Pharyngitis—Capecitabine—colon cancer	0.000402	0.00435	CcSEcCtD
Ciclesonide—Dyspnoea—Irinotecan—colon cancer	0.000383	0.00414	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Vincristine—colon cancer	0.000381	0.00412	CcSEcCtD
Ciclesonide—Fatigue—Vincristine—colon cancer	0.000381	0.00411	CcSEcCtD
Ciclesonide—Dyspepsia—Irinotecan—colon cancer	0.000379	0.00409	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000375	0.00406	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Irinotecan—colon cancer	0.000371	0.00401	CcSEcCtD
Ciclesonide—Fatigue—Irinotecan—colon cancer	0.000371	0.00401	CcSEcCtD
Ciclesonide—Dyspnoea—Fluorouracil—colon cancer	0.000367	0.00397	CcSEcCtD
Ciclesonide—Immune system disorder—Capecitabine—colon cancer	0.000366	0.00395	CcSEcCtD
Ciclesonide—NR3C1—lymphoid tissue—colon cancer	0.000365	0.0289	CbGeAlD
Ciclesonide—Mediastinal disorder—Capecitabine—colon cancer	0.000365	0.00395	CcSEcCtD
Ciclesonide—Dyspepsia—Fluorouracil—colon cancer	0.000363	0.00392	CcSEcCtD
Ciclesonide—NR3C1—digestive system—colon cancer	0.000361	0.0286	CbGeAlD
Ciclesonide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000356	0.00384	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Methotrexate—colon cancer	0.00035	0.00378	CcSEcCtD
Ciclesonide—Dysgeusia—Capecitabine—colon cancer	0.000345	0.00373	CcSEcCtD
Ciclesonide—Back pain—Capecitabine—colon cancer	0.000341	0.00369	CcSEcCtD
Ciclesonide—Pneumonia—Methotrexate—colon cancer	0.000338	0.00365	CcSEcCtD
Ciclesonide—Infestation NOS—Methotrexate—colon cancer	0.000336	0.00363	CcSEcCtD
Ciclesonide—Infestation—Methotrexate—colon cancer	0.000336	0.00363	CcSEcCtD
Ciclesonide—CYP3A4—renal system—colon cancer	0.000333	0.0263	CbGeAlD
Ciclesonide—NR3C1—bone marrow—colon cancer	0.000333	0.0263	CbGeAlD
Ciclesonide—CYP2D6—renal system—colon cancer	0.000327	0.0259	CbGeAlD
Ciclesonide—Urticaria—Fluorouracil—colon cancer	0.000327	0.00354	CcSEcCtD
Ciclesonide—Conjunctivitis—Methotrexate—colon cancer	0.000327	0.00353	CcSEcCtD
Ciclesonide—NR3C1—vagina—colon cancer	0.000319	0.0252	CbGeAlD
Ciclesonide—Epistaxis—Methotrexate—colon cancer	0.000317	0.00342	CcSEcCtD
Ciclesonide—Asthenia—Vincristine—colon cancer	0.000317	0.00342	CcSEcCtD
Ciclesonide—Palpitations—Capecitabine—colon cancer	0.000312	0.00337	CcSEcCtD
Ciclesonide—Asthenia—Irinotecan—colon cancer	0.000309	0.00333	CcSEcCtD
Ciclesonide—Cough—Capecitabine—colon cancer	0.000308	0.00333	CcSEcCtD
Ciclesonide—Hypertension—Capecitabine—colon cancer	0.000305	0.00329	CcSEcCtD
Ciclesonide—Haemoglobin—Methotrexate—colon cancer	0.000303	0.00328	CcSEcCtD
Ciclesonide—Haemorrhage—Methotrexate—colon cancer	0.000302	0.00326	CcSEcCtD
Ciclesonide—Arthralgia—Capecitabine—colon cancer	0.0003	0.00324	CcSEcCtD
Ciclesonide—Chest pain—Capecitabine—colon cancer	0.0003	0.00324	CcSEcCtD
Ciclesonide—Pharyngitis—Methotrexate—colon cancer	0.000299	0.00323	CcSEcCtD
Ciclesonide—Dry mouth—Capecitabine—colon cancer	0.000294	0.00317	CcSEcCtD
Ciclesonide—Dizziness—Vincristine—colon cancer	0.000292	0.00316	CcSEcCtD
Ciclesonide—Infection—Capecitabine—colon cancer	0.000286	0.00309	CcSEcCtD
Ciclesonide—Dizziness—Irinotecan—colon cancer	0.000284	0.00307	CcSEcCtD
Ciclesonide—Rash—Vincristine—colon cancer	0.000278	0.00301	CcSEcCtD
Ciclesonide—Dermatitis—Vincristine—colon cancer	0.000278	0.00301	CcSEcCtD
Ciclesonide—Headache—Vincristine—colon cancer	0.000277	0.00299	CcSEcCtD
Ciclesonide—CYP3A4—digestive system—colon cancer	0.000273	0.0216	CbGeAlD
Ciclesonide—Immune system disorder—Methotrexate—colon cancer	0.000272	0.00294	CcSEcCtD
Ciclesonide—Dizziness—Fluorouracil—colon cancer	0.000272	0.00294	CcSEcCtD
Ciclesonide—Mediastinal disorder—Methotrexate—colon cancer	0.000272	0.00294	CcSEcCtD
Ciclesonide—Rash—Irinotecan—colon cancer	0.000271	0.00293	CcSEcCtD
Ciclesonide—Dermatitis—Irinotecan—colon cancer	0.000271	0.00293	CcSEcCtD
Ciclesonide—Headache—Irinotecan—colon cancer	0.000269	0.00291	CcSEcCtD
Ciclesonide—NR3C1—liver—colon cancer	0.000269	0.0213	CbGeAlD
Ciclesonide—CYP2D6—digestive system—colon cancer	0.000269	0.0213	CbGeAlD
Ciclesonide—Nausea—Vincristine—colon cancer	0.000262	0.00283	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000262	0.00283	CcSEcCtD
Ciclesonide—Rash—Fluorouracil—colon cancer	0.00026	0.00281	CcSEcCtD
Ciclesonide—Dermatitis—Fluorouracil—colon cancer	0.00026	0.0028	CcSEcCtD
Ciclesonide—Headache—Fluorouracil—colon cancer	0.000258	0.00279	CcSEcCtD
Ciclesonide—Dysgeusia—Methotrexate—colon cancer	0.000257	0.00278	CcSEcCtD
Ciclesonide—Dyspnoea—Capecitabine—colon cancer	0.000257	0.00277	CcSEcCtD
Ciclesonide—Nausea—Irinotecan—colon cancer	0.000255	0.00276	CcSEcCtD
Ciclesonide—Back pain—Methotrexate—colon cancer	0.000254	0.00274	CcSEcCtD
Ciclesonide—Dyspepsia—Capecitabine—colon cancer	0.000253	0.00274	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000249	0.00269	CcSEcCtD
Ciclesonide—Fatigue—Capecitabine—colon cancer	0.000248	0.00268	CcSEcCtD
Ciclesonide—Nausea—Fluorouracil—colon cancer	0.000245	0.00264	CcSEcCtD
Ciclesonide—Cough—Methotrexate—colon cancer	0.000229	0.00248	CcSEcCtD
Ciclesonide—Urticaria—Capecitabine—colon cancer	0.000229	0.00247	CcSEcCtD
Ciclesonide—Arthralgia—Methotrexate—colon cancer	0.000224	0.00242	CcSEcCtD
Ciclesonide—Chest pain—Methotrexate—colon cancer	0.000224	0.00242	CcSEcCtD
Ciclesonide—Infection—Methotrexate—colon cancer	0.000213	0.0023	CcSEcCtD
Ciclesonide—Asthenia—Capecitabine—colon cancer	0.000207	0.00223	CcSEcCtD
Ciclesonide—NR3C1—lymph node—colon cancer	0.000206	0.0163	CbGeAlD
Ciclesonide—CYP3A4—liver—colon cancer	0.000203	0.0161	CbGeAlD
Ciclesonide—CYP2D6—liver—colon cancer	0.0002	0.0158	CbGeAlD
Ciclesonide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000195	0.00211	CcSEcCtD
Ciclesonide—Dyspnoea—Methotrexate—colon cancer	0.000191	0.00206	CcSEcCtD
Ciclesonide—Dizziness—Capecitabine—colon cancer	0.00019	0.00206	CcSEcCtD
Ciclesonide—Dyspepsia—Methotrexate—colon cancer	0.000189	0.00204	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000185	0.002	CcSEcCtD
Ciclesonide—Fatigue—Methotrexate—colon cancer	0.000185	0.002	CcSEcCtD
Ciclesonide—Rash—Capecitabine—colon cancer	0.000182	0.00196	CcSEcCtD
Ciclesonide—Dermatitis—Capecitabine—colon cancer	0.000181	0.00196	CcSEcCtD
Ciclesonide—Headache—Capecitabine—colon cancer	0.00018	0.00195	CcSEcCtD
Ciclesonide—Nausea—Capecitabine—colon cancer	0.000171	0.00185	CcSEcCtD
Ciclesonide—Urticaria—Methotrexate—colon cancer	0.00017	0.00184	CcSEcCtD
Ciclesonide—Asthenia—Methotrexate—colon cancer	0.000154	0.00166	CcSEcCtD
Ciclesonide—Dizziness—Methotrexate—colon cancer	0.000142	0.00153	CcSEcCtD
Ciclesonide—Rash—Methotrexate—colon cancer	0.000135	0.00146	CcSEcCtD
Ciclesonide—Dermatitis—Methotrexate—colon cancer	0.000135	0.00146	CcSEcCtD
Ciclesonide—Headache—Methotrexate—colon cancer	0.000134	0.00145	CcSEcCtD
Ciclesonide—Nausea—Methotrexate—colon cancer	0.000127	0.00138	CcSEcCtD
Ciclesonide—Methylprednisolone—ABCB1—colon cancer	0.00012	0.332	CrCbGaD
Ciclesonide—Prednisone—ABCB1—colon cancer	9.15e-05	0.254	CrCbGaD
Ciclesonide—Prednisolone—ABCB1—colon cancer	8.44e-05	0.234	CrCbGaD
Ciclesonide—Hydrocortisone—ABCB1—colon cancer	6.45e-05	0.179	CrCbGaD
